Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases

13 Nov 2004

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C virus research
Share to HIV/AIDS drug development and treatment
Share to HIV Research and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 15582396
DOI: 10.1016/j.sbi.2004.10.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptasesPMID 15582396Read ↗

Avoiding Drug Resistance in HIV Reverse Transcriptase.Semantic proximity Read ↗

HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistanceSemantic proximity Read ↗

HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistanceSemantic proximity Read ↗

How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?Semantic proximity Read ↗

HIV-1 entry inhibitors: Evading the issueSemantic proximity Read ↗

Novel approaches to inhibiting HIV-1 replicationSemantic proximity Read ↗

Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge TechnologySemantic proximity Read ↗

“Old Dogs with New Tricks”: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targetsSemantic proximity Read ↗

New perspective of small-molecule antiviral drugs development for RNA virusesSemantic proximity Read ↗

Rational design of 2-pyrrolinones as inhibitors of HIV-1 integraseSemantic proximity Read ↗

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance developmentSemantic proximity Read ↗

Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.